Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Neurogene Inc. (NASDAQ:NGNE) President and CFO Christine Mikail Cvijic sold 4,800 shares of the company's common stock in early July 2026, realizing a combined value of $173,375. The transactions were executed under a Rule 10b5-1 trading plan adopted in August 2025, with shares previously held jointly with her spouse. Following the sales, which occ…
Stuart Naylor, Chief Scientific Officer for Ophthalmology at MeiraGTx Holdings plc (NASDAQ: MGTX), executed a sale of ordinary shares totaling $409,470 on July 7, 2026. The transactions were conducted under a Rule 10b5-1 trading plan established on December 9, 2025. This sale activity coincides with a period of significant stock appreciation, corpo…
CrowdStrike Holdings Inc. (NASDAQ:CRWD) President and CEO George Kurtz sold 20,000 shares of Class A common stock in transactions executed on July 2 and July 6, 2026. The sales, valued at $3,975,888, were conducted under a Rule 10b5-1 plan established earlier in the year. This activity follows a significant four-for-one stock split and a period of …
Palantir Technologies Inc. (NASDAQ:PLTR) Chief Technology Officer and Executive Vice President Sankar Shyam executed a significant divestment of Class A Common Stock, totaling $24.05 million. The transaction, facilitated through a pre-arranged Rule 10b5-1 trading plan, involved the liquidation of 185,000 shares on July 2, 2026. This financial activ…
Kymera Therapeutics, Inc. (NASDAQ: KYMR) Chief Executive Officer Nello Mainolfi executed a significant stock sale on July 7, 2026, liquidating 50,000 shares for a total value of $5,950,000. The transaction occurred shortly after Mainolfi exercised stock options to acquire an equivalent number of shares at a substantially lower cost. This financial …
Damora Therapeutics, Inc. (NASDAQ: DMRA) reported a transaction involving its general counsel, Garrett Winslow, who sold 245 shares of the company's common stock on July 6, 2026. The sale, valued at $7,345, was executed at a price of $29.98 per share. This activity followed the settlement of 680 restricted stock units (RSUs) that vested on July 3, …
Guus Paul Wilhelm Franke, who serves as both Chairman and Chief Executive Officer of CIRCLE8 GROUP INC (NASDAQ:CIRC), executed a sale of 308,783 shares of the company’s common stock on July 1, 2026. The transaction, valued at $308,783, reflects an average sale price of $1.00 per share. This automated filing follows a recent leadership transition at…
Xu Cong Claire, Senior Vice President of Clinical Development at NovaBridge Biosciences, sold 4,485 ordinary shares on July 6, 2026, totaling $3,991. The transaction occurred as NBP shares trade at $2.02, down approximately 50% over the past six months. Prior to the sale, Claire acquired 12,432 ordinary shares through RSU exercises on July 4, 2026.…
Olesen Value Fund L.P., a major shareholder in Solitron Devices Inc. (NASDAQ:SODI), has liquidated a portion of its position, reporting sales totaling approximately $358,117. The transactions took place over a six-day window in early July 2026, coinciding with a period of significant price appreciation for the stock. The filing highlights the fund'…
Susan M. Byrne, Director Emerita at Westwood Holdings Group Inc. (NASDAQ:WHG), executed a series of stock sales totaling $164,877 between April and July 2026. All transactions were conducted under a Rule 10b5-1 trading plan adopted in April 2026. The sales occurred as WHG stock approached its 52-week high, while the company's first-quarter 2026 ear…
Thrivent Financial for Lutherans, a significant 10% stakeholder in Gloo Holdings, Inc., has executed a series of share sales totaling $97,760. This divestment occurs against a backdrop of recent price volatility and conflicting analyst signals, as the company reported substantial revenue growth while maintaining a negative earnings per share. The t…
Andreas Bechtolsheim, a significant shareholder in Arista Networks, executed a substantial sale of company stock in early July, reducing his indirect holdings while maintaining a large overall position. The transaction occurred amidst a backdrop of strong financial performance for the networking firm, which recently reported quarterly earnings that…
Brian E. Harding, the Chief Accounting Officer at Ultra Clean Holdings, Inc. (NASDAQ: UCTT), executed a series of stock sales totaling 3,837 shares on July 2, 2026. The transactions, valued at approximately $494,019, were conducted under a pre-arranged Rule 10b5-1 trading plan established earlier in the year. While the executive's sale reduces his …
Immunome Inc. director Isaac Barchas sold approximately $2.4 million worth of shares through a Rule 10b5-1 trading plan, reducing his indirect holdings while maintaining significant direct ownership. The transaction follows a substantial year-over-year stock appreciation and recent clinical developments that have prompted analyst upgrades.
Abhinav Shukla, Chief Technical Officer at Shattuck Labs, Inc. (NASDAQ: STTK), executed a sale of 410 shares on July 2, 2026, under a pre-arranged trading plan. The transaction, valued at $2,874, was facilitated by a Rule 10b5-1 plan adopted in February 2026 to cover option exercise costs and tax withholdings. The sale occurred as STTK stock traded…
Kuang Jin, Chief Financial Officer of Voip-Pal.com Inc (VPLM), executed a sale of company common stock on June 29, 2026, as documented in a recent SEC Form 4 filing. The transaction involved the disposal of 36,464 shares at a price of $0.0101 per share, resulting in a total transaction value of $368. Following this sale, Mr. Jin directly holds 2,32…
Harlan S. Robins, the Chief Scientific Officer at Adaptive Biotechnologies Corp., has executed a significant divestment of company stock, selling 386,240 shares for approximately $8.5 million. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which was established earlier this year. This sale occurs as the company's sto…
Gerrit S. Kazmaier, President of Product and Technology at Workday, Inc. (NASDAQ: WDAY), recently executed a series of stock transactions involving the company's Class A Common Stock. The sales were conducted under a Rule 10b5-1 trading plan and included both open market sales and shares withheld for tax obligations. These transactions occur as Wor…
Timothy Holme, Chief Technology Officer at QuantumScape Corp (NASDAQ: QS), executed a significant divestment of company shares on July 2, 2026, totaling approximately $999,565. The transactions, conducted through both direct sales and indirect dispositions via The Holme 2020 Irrevocable Trust, were carried out under a Rule 10b5-1 trading plan estab…
Opaleye Management Inc., a significant ten percent owner of Eton Pharmaceuticals, Inc. (NASDAQ:ETON), has executed a series of stock sales totaling approximately $4.77 million. These transactions, spanning from early July 2026, coincide with Eton's stock price approaching its 52-week high of $38.62. The sales reduce the investment firm's holdings, …
Jared F. Sine, GoDaddy's Chief Strategy and Legal Officer, executed a transaction on July 2, 2026, selling 644 shares of Class A Common Stock. The sale, valued at $56,369, was specifically structured to meet tax withholding requirements associated with the vesting of Restricted Stock Units, a standard procedure aligned with corporate policy. Follow…
Kevin Hettrich, Chief Financial Officer at QuantumScape Corp (NYSE: QS), executed a sale of 9,800 shares of the company's Class A Common Stock on July 2, 2026. The transaction, valued at $71,361, was conducted under a Rule 10b5-1 trading plan adopted in June 2025. This move occurs as QuantumScape navigates a period of stock volatility and announces…
Generac Holdings Inc. (NASDAQ: GNRC) President Norman P. Taffe sold 550 shares of common stock on July 6, 2026, generating $140,800 in proceeds. The transactions, executed at $256.0 per share, were conducted under a 10b5-1 trading plan established on March 6, 2026. This sale follows the exercise of stock options for 250 shares at $119.54 per share.…
Zscaler, Inc. (NASDAQ:ZS) Chief Legal Officer Robert Schlossman recently executed a sale of company stock valued at $18,300. The transaction, processed on July 6, 2026, involved the disposal of 122 shares at a price of $150 per share. This sale was conducted under a pre-arranged Rule 10b5-1 trading plan established on July 3, 2025. Following this t…
Jean Francois Formela, a director at Korro Bio, Inc. (NASDAQ:KRRO), executed a series of share sales in early July 2026, totaling approximately $1.54 million. These transactions, conducted under a Rule 10b5-1 trading plan established in April 2026, occurred while the biotech firm's stock experienced significant recent gains. The sales were facilita…
